Published in Ann Intern Med on February 01, 1970
A general theory of carcinogenesis. Proc Natl Acad Sci U S A (1973) 2.28
C-abl and bcr are rearranged in a Ph1-negative CML patient. EMBO J (1985) 1.08
Multiple myeloma superimposed on chronic myelocytic leukemia. Can Med Assoc J (1974) 0.84
Prognostic and predictive implications of Sokal, Euro and EUTOS scores in chronic myeloid leukaemia in the imatinib era-experience from a tertiary oncology centre in Southern India. Ecancermedicalscience (2016) 0.75
Males with chronic myeloid leukemia and the 45, XO, Ph1 chromosome pattern. Can Med Assoc J (1974) 0.75
Absence of the 9q plus chromosome in Ph1 negative chronic myelogenous leukaemia. J Med Genet (1974) 0.75
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med (1980) 6.12
Prognostic discrimination in "good-risk" chronic granulocytic leukemia. Blood (1984) 3.65
Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med (1993) 3.37
Editorial: Measurement of delayed skin-test responses. N Engl J Med (1975) 2.99
The LNCaP cell line--a new model for studies on human prostatic carcinoma. Prog Clin Biol Res (1980) 2.97
Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet (1986) 2.78
The journal "impact factor": a misnamed, misleading, misused measure. Cancer Genet Cytogenet (1998) 2.23
Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer (1999) 1.99
Culture of human leukemia cells. Cancer (1966) 1.94
Disappearance of a structural chromatin protein A24 in mitosis: implications for molecular basis of chromatin condensation. Proc Natl Acad Sci U S A (1979) 1.91
Whole-blood culture technique for functional studies of lymphocyte reactivity to mitogens, antigens, and homologous lymphocytes. J Lab Clin Med (1973) 1.75
Effect of vagotomy and vagal stimulation on insulin secretion. Diabetes (1967) 1.75
Characterization of a new primary human pancreatic tumor line. Cancer Invest (1986) 1.67
Lymphocyte response to phytohemagglutinin in Hodgkin's disease. Am J Med (1970) 1.56
Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). II. Biomarker studies. Cancer (1985) 1.51
Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet (1986) 1.49
Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). I. Clinical description of resource. Cancer (1985) 1.48
Isopeptidase: a novel eukaryotic enzyme that cleaves isopeptide bonds. Proc Natl Acad Sci U S A (1982) 1.47
Corticosteroid therapy for lymphomas and chronic lymphocytic leukemia. Cancer (1969) 1.44
Convention on nomenclature for DNA cytometry. Committee on Nomenclature, Society for Analytical Cytology. Cancer Genet Cytogenet (1984) 1.42
Trisomy 14: a new entity within acute nonlymphocytic leukemia. Cancer Genet Cytogenet (1989) 1.39
Involvement of 6p in benign lipomas. A new cytogenetic entity? Cancer Genet Cytogenet (1989) 1.39
Antagonism between the effects of insulin and glucagon on the isolated liver. Diabetes (1969) 1.34
Hybridization of nuclear matrix attached deoxyribonucleic acid fragments. Biochemistry (1981) 1.26
Translocation X;18 in synovial sarcoma. Cancer Genet Cytogenet (1986) 1.26
Clonal chromosomal abnormalities in desmoid tumors. Implications for histopathogenesis. Cancer (1992) 1.23
Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma. Cancer Res (1986) 1.22
In vitro lymphocyte response to autologous cultured lymphoid cells. Proc Soc Exp Biol Med (1971) 1.20
Quantitative conservation of chromatin-bound RNA polymerases I and II in mitosis. Implications for chromosome structure. J Cell Biol (1979) 1.20
Involvement of chromosome X in primary cytogenetic change in human neoplasia: nonrandom translocation in synovial sarcoma. Proc Natl Acad Sci U S A (1987) 1.20
Cytogenetic studies of adipose tissue tumors. II. Recurrent reciprocal translocation t(12;16)(q13;p11) in myxoid liposarcomas. Cancer Genet Cytogenet (1986) 1.19
The chromosomes and causation of human cancer and leukemia. Cancer Res (1966) 1.19
Cytogenetic findings in liposarcoma correlate with histopathologic subtypes. Cancer (1992) 1.18
Increased sister chromatid exchange in bone marrow and blood cells from Bloom's syndrome. Cytogenet Cell Genet (1976) 1.17
Induction of prophase in interphase nuclei by fusion with metaphase cells. J Cell Biol (1972) 1.16
Complications of BCG vaccination in neoplastic disease. Ann Intern Med (1975) 1.16
Use of Bacillus Calmette-Guérin as adjuvant in human cell vaccines. Cancer Res (1972) 1.15
A simplified technique for in vitro studies of lymphocyte reactivity. Proc Soc Exp Biol Med (1972) 1.12
Steroid receptors in exocrine glands: the pancreas and prostate. J Steroid Biochem (1979) 1.12
"Antigenic" disparity between cultured lymphoid cells and autologous lymphocytes. Am J Med (1972) 1.11
Three possible cytogenetic subgroups of leiomyosarcoma. Cancer Genet Cytogenet (1989) 1.11
Chromosomal abnormalities in human neoplasia. Annu Rev Med (1970) 1.10
Immunotherapy in well-controlled chronic myelocytic leukemia. N Y State J Med (1973) 1.10
Chromosome pulverization in human binucleate cells following colcemid treatment. J Cell Biol (1967) 1.09
BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study. Genes Chromosomes Cancer (1997) 1.08
Chromosomal abnormalities in leiomyosarcomas. Am J Pathol (1993) 1.07
Oral amphotericin for candidiasis in patients with hematologic neoplasms. An autopsy study. JAMA (1979) 1.07
Chromosomes and causation of human cancer and leukemia: XL. The Ph1 and other translocations in CML. Cancer (1980) 1.07
Chromosomes and causation of human cancer and leukemia. II. Karyotypes of human solid tumors. Cancer (1966) 1.07
Cytogenetic characterization of putative human myeloblastic leukemia cell lines (ML-1, -2, and -3): origin of the cells. Cancer Res (1986) 1.06
Cytogenetic analysis of dermatofibrosarcoma protuberans. Cancer Genet Cytogenet (1990) 1.06
Salmonellosis in disseminated malignant diseases. A seven-- year review (1959-1965). N Engl J Med (1967) 1.05
Elevated superoxide dismutase in Bloom's syndrome: a genetic condition of oxidative stress. Cancer Res (1989) 1.05
Glucagon--an essential hormone. Am J Med (1966) 1.05
Vinblastine vs. nitrogen mustard therapy of Hodgkin's disease. Cancer (1968) 1.05
Chronology and pattern of human chromosome replication, IV. Autoradiographic studies of binucleate cells. Proc Natl Acad Sci U S A (1966) 1.05
Sex chromosome aneuploidy and aging. Mutat Res (1995) 1.05
Translocation (X;1) in papillary renal cell carcinoma. A new cytogenetic subtype. Cancer Genet Cytogenet (1993) 1.05
Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system. Cancer Res (1982) 1.04
Characterization of the breakpoint of a t(14;14)(q11.2;q32) from the leukemic cells of a patient with T-cell acute lymphoblastic leukemia. Cancer Genet Cytogenet (1990) 1.03
Induction of nuclear envelopes around metaphase chromosomes after fusion with interphase cells. J Cell Biol (1971) 1.03
Chromosome pulverization in chinese hamster cells induced by Sendai virus. J Natl Cancer Inst (1968) 1.03
Relation of virus-induce cell fusion and chromosome pulverization to mitotic events. J Natl Cancer Inst (1969) 1.02
Vincristine therapy of lymphomas and chronic lymphocytic leukemia. Cancer (1970) 1.02
Phenotypic similarities and differences between CALLA-positive acute lymphoblastic leukemia cells and normal marrow CALLA-positive B cell precursors. Blood (1987) 1.01
Electron microscopic study of fused cells, with special reference to chromosome pulvrization. J Natl Cancer Inst (1970) 1.01
Aneuploidy and age in a population survey. Am J Hum Genet (1967) 1.01
Effect of glucagon on gluconeogenesis by the isolated perfused rat liver. Endocrinology (1966) 1.01
Misexpression of disrupted HMGI architectural factors activates alternative pathways of tumorigenesis. Cancer Res (1997) 1.00
Two discrete regions of deletion at 7q in uterine leiomyomas. Genes Chromosomes Cancer (1997) 0.99
A high-resolution study of chromosome changes in a human prostatic carcinoma cell line (LNCaP). Cancer Genet Cytogenet (1984) 0.98
Chlorambucil vs. combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemia. Cancer (1973) 0.98
Chromosome markers and progression in bladder cancer. Cancer Res (1977) 0.98
Delay in progression of malignant lymphoma after BCG vaccination. N Engl J Med (1974) 0.97
Benign monoclonal B cell lymphocytosis--a benign variant of CLL: clinical, immunologic, phenotypic, and cytogenetic studies in 20 patients. Blood (1984) 0.97
Second neoplasms with chronic lymphocytic leukemia. N Y State J Med (1976) 0.97
Analyses of bromodeoxyuridine-associated sister chromatid exchanges (SCEs) in Bloom syndrome based on cell fusion: single and twin SCEs in endoreduplication. Proc Natl Acad Sci U S A (1983) 0.97
Transcortin: a corticosteroid-binding protein of plasma. X. Cortisol and progesterone interplay and unbound levels of these steroids in pregnancy. J Clin Endocrinol Metab (1969) 0.97
A pilot study of the Functional Living Index-Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study. Am J Clin Oncol (1988) 0.96
Chromosomes in the diagnosis of soft tissue tumors. I. Synovial sarcoma. Mod Pathol (1992) 0.96
Chromosome pulverization in human cells with micronuclei. J Natl Cancer Inst (1968) 0.96
Chromosome changes in malignant mesothelioma. Cancer Genet Cytogenet (1986) 0.96
Dimorphism of sister chromatid exchange in Bloom's syndrome B- and T-cell lines transformed with Epstein-Barr and adult T-cell leukemia viruses. Cancer Res (1983) 0.95
Nodular mixed lymphoma: results of a randomized trial failing to confirm prolonged disease-free survival with COPP chemotherapy. Blood (1981) 0.95
Nomenclature: the Philadelphia chromosome or Ph without superscript. Cancer Genet Cytogenet (1985) 0.95
Fate of chromatin of interphase nuclei subjected to "phosphasing" in virus-fused cells. J Natl Cancer Inst (1972) 0.95
Specific cytogenetic changes in ovarian cancer involving chromosomes 6 and 14. Cancer Res (1980) 0.95
Unbalanced chromosomal translocation, der(17)t(13;17)(q14;p11) in a solid and cystic papillary epithelial neoplasm of the pancreas. Am J Surg Pathol (1996) 0.94
Acute myeloblastic leukemia (AML) with t(6;9) (p23;q34): a specific subgroup of AML? Cancer Genet Cytogenet (1983) 0.94
The effect of intensive intermittent maintenance therapy in advanced low-grade non-Hodgkin's lymphoma. Cancer (1987) 0.94
Consistent breakpoints in region 14q22-q24 in uterine leiomyoma. Cancer Genet Cytogenet (1988) 0.94
Chromosome changes in soft tissue sarcomas. J Natl Cancer Inst (1984) 0.93
Uterine leiomyomas: cytogenetic and histologic profile. Obstet Gynecol (1992) 0.93
Cytogenetic and molecular genetic techniques as adjunctive approaches in the diagnosis of bone and soft tissue tumors. Skeletal Radiol (2000) 0.93
Pyrogen in the urine of febrile patients with Hodgkin's disease. Nature (1967) 0.93
The basis of chromatin fiber assembly within chromosomes studied by histone-DNA crosslinking followed by trypsin digestion. Chromosoma (1980) 0.93
Translocations involving the X chromosome in solid tumors: presentation of two sarcomas with t(X;18)(q13;p11). Cancer Genet Cytogenet (1986) 0.93
Dependence of chromosome pulverization in virus-fused cells on events in the G2 period. J Natl Cancer Inst (1971) 0.93
Chromosomes and causation of human cancer and leukemia. V. Karyotypic aspects of acute leukemia. Cancer (1968) 0.93
Molecular and cytogenetic analysis of chromosome 7 in uterine leiomyomas. Genes Chromosomes Cancer (1995) 0.93